Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Jul. 31, 2025	Jul. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ (8,360,096)	$ 23,421,355
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on related party investment – TNF	0	(21,395,734)
Adjustment from accrued liabilities to warrant liabilities	(469,000)	0
Gain on re-fair value of warrants	(106,000)	0
Stock-based compensation	60,492	222,677
Unrealized loss on marketable equity securities	104,463	0
Change in fair value of warrant liabilities	(243,000)	(2,084,000)
Change in fair value of derivative liability	0	(1,204,000)
Change in fair value of convertible note receivable - Femasys	(912,000)	(245,000)
Change in fair value of warrant asset – Femasys	1,215,000	1,510,000
Change in fair value of investment – TNF	2,839,000	(966,950)
Change in fair value of warrants - TNF	4,832,000	242,684
Change in assets and liabilities:
(Increase) decrease in prepaid expenses and other current assets	(14,421)	19,573
Increase in accounts payable	66,005	164,582
Decrease in accrued expenses	(1,006,424)	(58,484)
Net cash and cash equivalents used in operating activities	(1,993,981)	(373,297)
Cash flows from investing activities:
Investment in preferred stock and warrants	0	(7,000,000)
Net cash and cash equivalents used in investing activities	0	(7,000,000)
Cash flows from financing activities:
Repurchase of common stock, net	0	(742,179)
Redemption of preferred stock	0	(9,429,583)
Net cash and cash equivalents used in financing activities	0	(10,171,762)
Effect of currency rate exchange on cash and cash equivalents	123	183
Net decrease in cash and cash equivalents	(1,993,858)	(17,544,876)
Cash and cash equivalents at beginning of the period	15,172,163	50,179,968
Cash and cash equivalents at end of the period	13,178,305	32,635,092
Supplemental disclosure of cash flows information:
Cash paid during the periods for income taxes
Cash paid during the periods for interest
Supplemental disclosure of non-cash investing and financing activities:
Reclassification of Series B Convertible Preferred Stock and dividends to current liability	0	9,367,750
Accretion of discounts to redemption value of Series B Preferred Stock	0	2,148,047
Excise tax accrued on repurchase of common stock	$ 0	$ 7,421